Development of collagenase-resistant collagen and its interaction with adult human dermal fibroblasts

被引:89
作者
Goo, HC
Hwang, YS
Choi, YR
Cho, HN
Suh, H
机构
[1] Yonsei Univ, Coll Med, Dept Med Engn, Seodaemun Ku, Seoul, South Korea
[2] RegenMed Inc, Seodaemun Ku, Seoul, South Korea
[3] KIST, Polymer Mat Lab, Seoul, South Korea
关键词
EGCG; collagen; collagenase resistance; structural stability; free-radical scavenging activity; cell adhesion; actin filament;
D O I
10.1016/S0142-9612(03)00431-9
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Collagen is regarded as one of the most useful biomaterials. The excellent biocompatibility and safety due to its biological characteristics, such as biodegradability and weak antigenecity, made collagen the primary source in biomedical application. Collagen has been widely used in the crosslinked form to extend the durability of collagen. The chemical treatment influences the structural integrity of collagen molecule resulting in the loss of triple helical characteristic. The structural characteristic of collagen is importantly related to its biological function for the interaction with cell. In this study, structural stability of collagen was enhanced thought EGCG treatment, resulting in high resistance against degradation by bacterial collagenase and MMP-1, which is confirmed by collagen zymography. The triple helical structure of EGCG-treated collagen could be maintained at 37degreesC in comparison with collagen, which confirmed by CD spectra analysis, and EGCG-treated collagen showed high free-radical scavenging activity. Also, with fibroblasts culture on EGCG-treated collagen, the structural stability of EGCG-treated collagen provided a favorable support for cell function in cell adhesion and actin filament expression. These observations underscore the need for native, triple helical collagen conformation as a prerequisite for integrin-mediated cell adhesion and functions. According to this experiment, EGCG-treated collagen assumes to provide a practical benefit to resist the degradation by collagenase retaining its structural characteristic, and can be a suitable biomaterial for biomedical application. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5099 / 5113
页数:15
相关论文
共 58 条
[31]  
MATEOS PS, 1996, SEMIN CANCER BIOL, V7, P99
[32]   REGULATION OF COLLAGEN-SYNTHESIS IN FIBROBLASTS WITHIN A 3-DIMENSIONAL COLLAGEN GEL [J].
MAUCH, C ;
HATAMOCHI, A ;
SCHARFFETTER, K ;
KRIEG, T .
EXPERIMENTAL CELL RESEARCH, 1988, 178 (02) :493-503
[33]   IMMUNOGENICITY OF COLLAGENOUS IMPLANTS [J].
MEADE, KR ;
SILVER, FH .
BIOMATERIALS, 1990, 11 (03) :176-180
[34]  
MIDDETON E, 1991, BIOCHEM PHARMACOL, V43, P1167
[35]   CLEAVAGE OF TYPE-2 AND TYPE-3 COLLAGENS WITH MAMMALIAN COLLAGENASE - SITE OF CLEAVAGE AND PRIMARY STRUCTURE AT NH2-TERMINAL PORTION OF SMALLER FRAGMENT RELEASED FROM BOTH COLLAGENS [J].
MILLER, EJ ;
HARRIS, ED ;
CHUNG, E ;
FINCH, JE ;
MCCROSKERY, PA ;
BUTLER, WT .
BIOCHEMISTRY, 1976, 15 (04) :787-792
[36]  
MUKHOPADHYAY CK, 1994, J BIOL CHEM, V269, P30200
[37]   Succinylated collagen crosslinked by thermal treatment for coating vascular prostheses [J].
Noishiki, Y ;
Ma, XH ;
Yamane, Y ;
Satoh, S ;
Okoshi, T ;
Takahashi, K ;
Iwai, Y ;
Kosuge, T ;
Ichikawa, Y ;
Yamazaki, I ;
Mo, M .
ARTIFICIAL ORGANS, 1998, 22 (08) :672-680
[38]  
NUSGENS B, 1984, COLLAGEN REL RES, V4, P351
[39]  
Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO
[40]  
2-L